These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9950893

  • 21. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
    Brunner F.
    Cardiovasc Res; 1999 Oct; 44(1):197-206. PubMed ID: 10615403
    [Abstract] [Full Text] [Related]

  • 22. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS.
    Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924
    [Abstract] [Full Text] [Related]

  • 23. Selective right, but not left, coronary endothelial dysfunction precedes development of pulmonary hypertension and right heart hypertrophy in rats.
    Sun X, Ku DD.
    Am J Physiol Heart Circ Physiol; 2006 Feb 25; 290(2):H758-64. PubMed ID: 16172159
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the rat by a novel selective endothelin-A receptor antagonist, di-n-butylaminocarbamyl-L-leucyl-D-tryptophanyl-D-4-chloro-Phe.
    Yan LD, Kong LL, Yong Z, Dong HJ, Chi MG, Pan XF, Zhang C, Liang YJ, Gong ZH, Liu KL.
    J Cardiovasc Pharmacol; 2010 Sep 25; 56(3):246-54. PubMed ID: 20531217
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
    Voelkel NF, Tuder RM, Bridges J, Arend WP.
    Am J Respir Cell Mol Biol; 1994 Dec 25; 11(6):664-75. PubMed ID: 7946395
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels.
    Goirand F, Bardou M, Guerard P, Dumas JP, Rochette L, Dumas M.
    J Cardiovasc Pharmacol; 2003 Jan 25; 41(1):117-25. PubMed ID: 12500029
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
    Li X, Liu KL, Zheng JQ, Chi MG, Dong JJ, Dong SJ, Gong ZH.
    Pulm Pharmacol Ther; 2008 Oct 25; 21(5):780-7. PubMed ID: 18602014
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
    Falcão-Pires I, Gonçalves N, Henriques-Coelho T, Moreira-Gonçalves D, Roncon-Albuquerque R, Leite-Moreira AF.
    Am J Physiol Heart Circ Physiol; 2009 Jun 25; 296(6):H2007-14. PubMed ID: 19346461
    [Abstract] [Full Text] [Related]

  • 40. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats.
    Bal E, Ilgin S, Atli O, Ergun B, Sirmagul B.
    Hum Exp Toxicol; 2013 Jul 25; 32(7):766-74. PubMed ID: 23821593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.